lovastatin has been researched along with Plasmacytoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloem, AC; Kamphuis, MM; Lokhorst, HM; van de Donk, NW | 1 |
1 other study(ies) available for lovastatin and Plasmacytoma
| Article | Year |
|---|---|
The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells.
Topics: Anticholesteremic Agents; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Division; Down-Regulation; Humans; Lovastatin; Plasmacytoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2002 |